Exagen Inc. (XGN)
NASDAQ: XGN
· Real-Time Price · USD
7.01
0.04 (0.57%)
At close: Jun 24, 2025, 3:59 PM
0.57% (1D)
| Bid | 5.08 |
| Market Cap | 153.2M |
| Revenue (ttm) | 56.72M |
| Net Income (ttm) | -15.51M |
| EPS (ttm) | -0.84 |
| PE Ratio (ttm) | -8.35 |
| Forward PE | -27.54 |
| Analyst | Strong Buy |
| Ask | 8.81 |
| Volume | 533,860 |
| Avg. Volume (20D) | 237,570 |
| Open | 7.06 |
| Previous Close | 6.97 |
| Day's Range | 6.85 - 7.10 |
| 52-Week Range | 1.71 - 7.95 |
| Beta | 1.60 |
Analyst Forecast
According to 0 analyst ratings, the average rating for XGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Exagen Inc. is scheduled to release its earnings on Aug 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-9.81%
Exagen shares are trading lower after the company ...
Unlock content with
Pro Subscription
10 months ago
+12.65%
Exagen shares are trading higher after the company reported better-than-expected Q2 financial results and increased its FY24 revenue outlook above estimates.
